A Portfolio Analysis and Innovation Policy of Taiwan''s DNA Chips Industry

碩士 === 國立交通大學 === 科技管理所 === 90 === This thesis reports a strategic analysis on the development of Taiwan’s DNA chips industry. A portfolio model is used to assess competitive and strategy requirements for the development. An attempt is also made to provide policy recommendations, as demanded by indu...

Full description

Bibliographic Details
Main Authors: Yu-cheng Huang, 黃煜程
Other Authors: Joseph Z. Shyu
Format: Others
Language:zh-TW
Published: 2002
Online Access:http://ndltd.ncl.edu.tw/handle/66318688584032430844
Description
Summary:碩士 === 國立交通大學 === 科技管理所 === 90 === This thesis reports a strategic analysis on the development of Taiwan’s DNA chips industry. A portfolio model is used to assess competitive and strategy requirements for the development. An attempt is also made to provide policy recommendations, as demanded by industrial firms, to the government. The portfolio model entails a 2-dimensional analysis, containing Taiwan’s market s-curve (vertical axis) and the supply chain (horizontal). Three research methods are used for data collection, which include literature review, expert interview, and general survey. The DNA chips industry is positioned between the burgeoning phase and the developing phase of the market s-curve, and between the fundamental research and the applied research of the biochip industry supply chain. The development of the DNA chip market is limited to the costs, but it will orient toward the applied research after cost reduction. Evaluating the Industrial Innovation Requirements and Policy Tools leads to a recommendation that the most critical categories of policy instruments be Public Enterprise, Scientific and Technical Development, Education, and Financial. More specifically, the government should help industrial firms to form a large network specializing in biochip technology, provide rewards for innovation and experimental equipments, and develop expertise to expedite the developments of knowledge in the industry. Moreover, the government should also help form effective capitalization means, including grants, bank loans, and venture capital funds help the research institutions and biotech companies obtain needed financial.